Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR.
about
Acute reductions in mechanical wall strain precede the formation of intimal hyperplasia in a murine model of arterial occlusive disease.Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice.Application of in utero electroporation of G-protein coupled receptor (GPCR) genes, for subcellular localization of hardly identifiable GPCR in mouse cerebral cortex.Lysophosphatidic acid in atherosclerotic diseasesAiming drug discovery at lysophosphatidic acid targets.Lysophosphatidic acid induces integrin activation in vascular smooth muscle and alters arteriolar myogenic vasoconstriction.Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.Vascular involvement in systemic sclerosis (scleroderma).Pathogenesis of Systemic Sclerosis.Pharmacological repression of PPARγ promotes osteogenesisPhospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid.Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering.Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats.LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.G-protein-mediated signaling in vascular smooth muscle cells - implications for vascular disease.Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61.Lysophosphatidic acid effects on atherosclerosis and thrombosis.Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia.Cyclic phosphatidic acid inhibits alkyl-glycerophosphate-induced downregulation of histone deacetylase 2 expression and suppresses the inflammatory response in human coronary artery endothelial cells.
P2860
Q30399953-F71A251B-0DC3-47A0-80EB-1492E48412E7Q30410474-8221900B-7445-4A1E-AABB-28A0EE6EFFB9Q34043023-3172203F-1A04-40C4-8B56-BE3729D32DEBQ34273486-4EACEEF4-3394-4A83-BE4B-0B643E8AD932Q34339759-DCEFD230-F3B6-451E-ACB5-8DEC4F426BD8Q34433358-F7F57572-02DB-41F1-AFCE-DB93AC210543Q35551835-020CC2A1-EC9A-44B7-ADD8-63B7C46982C9Q35557424-9189A8B6-2DB4-4E26-8537-42AF9862A039Q35693212-4D9201D9-53BE-4E3A-962E-74266D086F12Q35754510-D88149E7-C57F-4447-BC53-828DBE42FE16Q36246883-3D9C91D1-92C8-4F21-BFBA-80F15B27FEA5Q36330107-E9C28095-B838-402D-8A4E-CC3E072A0BCCQ36783324-B9F7EE0B-6FDC-4F37-8F94-48B40AD91B06Q36940630-8418FE97-2F17-42B4-91CC-4A4166108A78Q37620329-5AB4F48F-4490-49C5-9A74-DCDDE571B065Q38526491-3E1415C6-FFAB-41BE-BFD7-0D730A15A035Q39269910-2837AC8B-0846-4702-B270-8D0D0646DAE0Q39608397-34C0CE6F-3262-4DE6-AA03-7B1F8194C45AQ42414579-141D6089-B39B-43CF-BE16-92F5DEA66079Q42720236-460F7494-CB7A-464C-A188-D4D09E844E17
P2860
Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lysophosphatidic acid-induced ...... mma but not LPA1 or LPA2 GPCR.
@en
Lysophosphatidic acid-induced ...... mma but not LPA1 or LPA2 GPCR.
@nl
type
label
Lysophosphatidic acid-induced ...... mma but not LPA1 or LPA2 GPCR.
@en
Lysophosphatidic acid-induced ...... mma but not LPA1 or LPA2 GPCR.
@nl
prefLabel
Lysophosphatidic acid-induced ...... mma but not LPA1 or LPA2 GPCR.
@en
Lysophosphatidic acid-induced ...... mma but not LPA1 or LPA2 GPCR.
@nl
P2093
P2860
P1433
P1476
Lysophosphatidic acid-induced ...... mma but not LPA1 or LPA2 GPCR.
@en
P2093
Chunxiang Zhang
Gabor Tigyi
Huazhang Guo
Louisa Balazs
Natalia Makarova
Patricia Farrar
Ryoko Tsukahara
Yunhui Cheng
P2860
P304
P356
10.1016/J.CELLSIG.2009.08.003
P577
2009-08-23T00:00:00Z